Skip to content
10-K

Annual Report

NUTRA PHARMA CORP. NPHC

0001641172-25-026446

← back to feed
Filed
Sep 3, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Sep 3, 2025 7.1B sh
Shares Diluted FY 2022 · Dec 31, 2021 7.23B sh
Capex FY 2022 · Dec 31, 2021 $39.04K
Operating Cash Flow FY 2022 · Dec 31, 2021 −$1.74M
Short Term Debt FY 2022 · Dec 31, 2021 $7.6M
Current Liabilities FY 2022 · Dec 31, 2021 $21.14M
Total Liabilities FY 2022 · Dec 31, 2021 $21.66M
Current Assets FY 2022 · Dec 31, 2021 $533.83K
Total Assets FY 2022 · Dec 31, 2021 $780.02K
Eps Diluted FY 2022 · Dec 31, 2021 −$0.00
Eps Basic FY 2022 · Dec 31, 2021 −$0.00
Sga Expense FY 2022 · Dec 31, 2021 $1.93M
Net Income FY 2022 · Dec 31, 2021 −$13.1M
Operating Income FY 2022 · Dec 31, 2021 −$1.99M
Gross Profit FY 2022 · Dec 31, 2021 $8.47K
Revenue FY 2022 · Dec 31, 2021 $97.74K
Stockholders Equity FY 2022 · Dec 31, 2020 −$11.49M